Memgen, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors (NCT05076760) | Memgen, Inc. | 2022-04-21 |
Track Memgen, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.